Evidence map›Paper›PMID 39222131›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM).

Rossana Berardi, Alessandro Parisi, Marco Maruzzo, Marco Bellani, Giordano Domenico Beretta, Mauro Boldrini, Luigi Cavanna, Stefania Gori, Elisabetta Iannelli, Anna Maria Mancuso and 8 more

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Rossana BerardiMedical Oncology, Azienda Ospedaliera Universitaria (AOU) Delle Marche, Università Politecnica Delle Marche, Ancona, Italy.
Alessandro ParisiMedical Oncology, Azienda Ospedaliera Universitaria (AOU) Delle Marche, Università Politecnica Delle Marche, Ancona, Italy. alexparis@hotmail.it.
Marco MaruzzoOncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
Marco BellaniPsycho-Oncology Unit, Department of Medicine and Innovation Technology, University of Insubria, Varese, Italy.
Giordano Domenico BerettaUOC Oncologia Medica, ASL Pescara P.O., Pescara, Italy.
Mauro BoldriniItalian Foundation of Medical Oncology (Fondazione AIOM), Milan, Italy.
Luigi CavannaCasa Di Cura Piacenza, Internal Medicine and Oncology, Via Morigi 41, 29121, Piacenza, Italy.
Stefania GoriDepartment of Medical Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar Di Valpolicella, Verona, Italy.
Elisabetta IannelliItalian Federation of Volunteer-Based Cancer Organizations (FAVO), Rome, Italy.
Anna Maria MancusoAssociazione Salute Donna Onlus, Milan, Italy.
Massimiliano MarinelliPrimary Care Physician, Bioethicist and Professor of Narrative Medicine, Ancona, Italy.
Vera MartinellaScientific Journalist for Umberto Veronesi Foundation and Corriere Della Sera, Milan, Italy.
Michele MussoWHIN (Web Health Information Network), Milan, Italy.
Roberto PapaRisk Management and Health Technology Innovation Unit, Department of Staff, AOU Delle Marche, 60126, Ancona, Italy.
Antonio RussoDepartment of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
Valentina TarantinoMedical Oncology, Azienda Ospedaliera Universitaria (AOU) Delle Marche, Università Politecnica Delle Marche, Ancona, Italy.
Mirella TarantoItalian National Institute of Health, Rome, Italy.
Saverio CinieriMedical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo identify barriers between health and communication in oncology in order to promote the best possible practice. The areas of communication to be focused on are communication directly with the patient, communication within the scientific community, and communication with the media. MATERIAL AND

methodsA working group including eminent experts from the national mass media, healthcare system, and patients' advocacy has been established on behalf of the Italian Association of Medical Oncology (AIOM), with the aim of developing suitable recommendations for the best communication in oncology. A literature search has been conducted selecting primary studies related to the best practices applied to communication in oncology. Subsequent to having identified the most representative statements, through a consensus conference using the RAND/University of California Los Angeles modified Delphi method, the panel evaluated the relevance of each statement to support useful strategies to develop effective communication between oncologist physicians and patients, communication within the scientific community, and communication with media outlets, including social media.

resultsA total of 292 statements have been extracted from 100 articles. Following an evaluation of relevance, it was found that among the 142 statements achieving the highest scores, 30 of these have been considered of particular interest by the panel.

conclusionsThis consensus and the arising document represent an attempt to strengthen the strategic alliance between key figures in communication, identifying high-impact recommendations for the management of communication in oncology with respect to patients, the wider scientific community, and the media.

Indexed as

CommunicationDelphi TechniqueMedical OncologyHealth PersonnelHumansItalyMass MediaNeoplasmsPhysician-Patient RelationsSocieties, MedicalCancerJournalismMediaPatientScientific communitySocial network

Identifiers

PMID39222131
PMCPMC11369048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.